STAT6 mutations, frequently detected in follicular lymphoma and other BCLs, point to a potential overlap in the IL-4/JAK/STAT6 signaling pathway involved in both AD and lymphoma pathogenesis (69–71). This evidence concerns the gene STAT6 and follicular lymphoma.